Simcoe Capital Management’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,708,095
Closed -$48M 13
2023
Q2
$48M Hold
1,708,095
6.12% 7
2023
Q1
$38.1M Buy
1,708,095
+105,582
+7% +$2.77M 4.98% 10
2022
Q4
$42.6M Sell
1,602,513
-675,585
-30% -$22.1M 4.64% 10
2022
Q3
$64.6M Buy
2,278,098
+1,134,473
+99% +$29.2M 9.12% 4
2022
Q2
$23.8M Buy
+1,143,625
New +$21.4M 3.28% 13
2017
Q3
Sell
-1,227,590
Closed -$15.8M 14
2017
Q2
$15.8M Buy
1,227,590
+671,885
+121% +$8.66M 6.89% 8
2017
Q1
$7.98M Hold
555,705
3.65% 11
2016
Q4
$8.68M Buy
555,705
+202,155
+57% +$2.77M 4.26% 7
2016
Q3
$4.17M Buy
+353,550
New +$4.66M 2.19% 13

Other funds holding CCRN

Simcoe Capital Management's CCRN Position: Q3 2023 in Review

Simcoe Capital Management sold out of Cross Country Healthcare (CCRN) in Q3 2023, closing a stake of 1,708,095 shares — an estimated $48M sold.

Simcoe Capital Management first reported a position in CCRN in Q3 2016 and held it in 9 quarters. The position peaked at $64.6M in Q3 2022. 189 funds tracked by Wall St. Rank hold CCRN as of Q3 2023.

  • Simcoe Capital Management reported no remaining Cross Country Healthcare position as of Q3 2023 after selling out during the quarter.
  • Simcoe Capital Management sold 1,708,095 Cross Country Healthcare shares in Q3 2023, an estimated $48M.
  • Simcoe Capital Management first reported a position in Cross Country Healthcare in Q3 2016 and held it in 9 quarters.
  • Simcoe Capital Management's Cross Country Healthcare position peaked at $64.6M in Q3 2022.
  • 189 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q3 2023.

Based on Simcoe Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.